TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that aspects of its immuno-oncology programs and its lead autoimmune program will be presented at four upcoming scientific conferences.
Help employers find you! Check out all the jobs and post your resume.
